Safety and Tolerability Open Label Dose Escalation Study of Acadesine in B-CLL Patients

NCT00559624 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia, B-Cell, Chronic

Interventions

DRUG: Acadesine

Sponsor

Advancell - Advanced In Vitro Cell Technologies, S.A.

Collaborators

[object Object]